C. Lozano

Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

E. Ruiz-Mateos, M. Leal, I. Herrero-Fernández, 2018, Journal of Translational Medicine.

Improved CD4 T-cell profile and inflammatory levels in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination

E. Ruiz-Mateos, M. Leal, I. Rosado-Sánchez, 2018, bioRxiv.

Antibody response in patients admitted to the hospital with suspected SARS-CoV-2 infection: results from a multicenter study across Spain

C. Lozano, I. Fernández-Natal, Federico García, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Title: Improved CD4 T-cell profile and inflammatory levels in HIV-infected subjects

E. Ruiz-Mateos, M. Leal, I. Rosado-Sánchez, 2018 .

Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients

M. M. Pozo-Balado, C. Lozano, Y. Pacheco, 2023, Frontiers in Immunology.

Long-Term Hepatitis B Virus Surface Antigen Decay in HIV-1/Hepatitis B Virus-Coinfected Adults Initiating a Tenofovir-Containing Regimen

P. Van de Perre, C. Lozano, N. Nagot, 2012, Journal of Clinical Microbiology.

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered

C. Lozano, L. López-Cortés, N. Espinosa, 2023, Frontiers in Immunology.

Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home

M. Leal, M. M. Pozo-Balado, C. Lozano, 2023, Immunity & Ageing.

Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors

C. Lozano, A. Gutiérrez-Valencia, Esperanza Muñoz-Muela, 2024, Frontiers in immunology.